BRIEF published on 11/05/2024 at 10:12, 1 year 7 months ago Leadership Transition at PharmaSGP Holding SE: Peter Gerckens to Succeed Natalie Weigand as CEO Company Growth OTC Pharmaceuticals Peter Gerckens Natalie Weigand PharmaSGP Leadership Change
PRESS RELEASE published on 11/05/2024 at 10:07, 1 year 7 months ago CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as of January 1, 2025 PharmaSGP Holding SE announces CEO change with Peter Gerckens succeeding Natalie Weigand on January 1, 2025. Smooth transition planned for internal succession Succession Plan CEO Change PharmaSGP Holding SE Peter Gerckens Natalie Weigand
BRIEF published on 11/05/2024 at 10:07, 1 year 7 months ago Leadership Change at PharmaSGP Holding SE: Peter Gerckens Appointed CEO Leadership Transition CEO Change PharmaSGP Holding SE Peter Gerckens Natalie Weigand
PRESS RELEASE published on 11/05/2024 at 10:02, 1 year 7 months ago EQS-Adhoc: PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer PharmaSGP Holding SE appoints Peter Gerckens as new CEO, succeeding Natalie Weigand. Gerckens, currently CCO, will assume the CEO position on January 1, 2025 Supervisory Board PharmaSGP Holding SE CEO Succession Peter Gerckens Natalie Weigand
BRIEF published on 10/01/2024 at 08:20, 1 year 8 months ago PharmaSGP Holding SE Acquires 477,701 Shares Through Repurchase Offer Share Buyback Treasury Shares Capital Reduction PharmaSGP Repurchase Offer
PRESS RELEASE published on 10/01/2024 at 08:15, 1 year 8 months ago PharmaSGP Holding SE has purchased 477,701 own shares through its public share repurchase offer PharmaSGP Holding SE has purchased 477,701 own shares through public share repurchase offer. The company's acceptance ratio is approximately 80.37% Share Buyback Treasury Shares Public Offer PharmaSGP Holding Acceptance Ratio
BRIEF published on 09/12/2024 at 08:20, 1 year 9 months ago PharmaSGP Continues Dynamic Growth Path in First Half of 2024 Revenue Growth International Expansion PharmaSGP OTC Pharmaceuticals 2024 Financials
BRIEF published on 09/12/2024 at 08:15, 1 year 9 months ago PharmaSGP Holding SE Announces Share Repurchase Program Share Repurchase Acceptance Period PharmaSGP Holding SE 594,405 Shares EUR 21.45
PRESS RELEASE published on 09/12/2024 at 08:15, 1 year 9 months ago PharmaSGP continues dynamic growth path in the first half of 2024 PharmaSGP Holding SE reports dynamic growth with half-year revenues reaching €58.4 million, up 17.4% from last year. Management expects full-year revenues to range from €107.0m to €112.0m Revenues Germany Growth Internationalization PharmaSGP
PRESS RELEASE published on 09/12/2024 at 08:10, 1 year 9 months ago EQS-Adhoc: PharmaSGP Holding SE resolves on public share repurchase offer to buy back own shares for up to 594,405 shares PharmaSGP Holding SE announces public share repurchase offer to buy back own shares for up to 594,405 shares, with acceptance period from September 13 to 26, 2024 Acceptance Period 2024 PharmaSGP Holding SE 594,405 Shares Share Repurchase Offer
Published on 06/19/2026 at 04:30, 17 hours 44 minutes ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 20 hours 54 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 21 hours 7 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 22 hours 14 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/19/2026 at 20:17, 1 hour 56 minutes ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 3 hours 12 minutes ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:00, 4 hours 14 minutes ago Successful issue of a CHF 100 million green bond
Published on 06/19/2026 at 16:30, 5 hours 44 minutes ago Amrize to Modernize Montreal Area Cement Plant to be Most Advanced in Eastern Canada
Published on 06/19/2026 at 19:33, 2 hours 40 minutes ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 hours 50 minutes ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 1 day 4 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 1 day 4 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 1 day 4 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
